Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narciso Olvera

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 24, 2011
Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinomaRobert A Soslow, Guangming Han, Kay J Park, et al.
Gynecologic Oncology|November 22, 2012
Validated gene targets associated with curatively treated advanced serous ovarian carcinomaJoyce N Barlin, Petar Jelinic, Narciso Olvera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2014
Blocking and randomization to improve molecular biomarker discoveryLi-Xuan Qin, Qin Zhou, Faina Bogomolniy, et al.
The American Journal of Surgical Pathology|December 13, 2012
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomasKaruna Garg, Douglas A Levine, Narciso Olvera, et al.
Gynecologic Oncology|September 23, 2022
The role of CTNNB1 mutations and matrix metalloproteinases (MMPs) in anti-angiogenesis treatment of endometrial carcinomaAmnon A Berger, Emily A Kawaler, Fanny Dao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2015
Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic typePetar Jelinic, Brooke A Schlappe, Niamh Conlon, et al.
Scientific Reports|June 17, 2017
miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine CarcinosarcomasJill H Tseng, Maria Bisogna, Lien N Hoang, et al.
Gynecologic Oncology|March 1, 2011
A microRNA survival signature (MiSS) for advanced ovarian cancerKarin K Shih, Li-Xuan Qin, Edward J Tanner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinomaDestin Black, Robert A Soslow, Douglas A Levine, et al.
Nature Communications|October 19, 2017
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinomaJennifer Ducie, Fanny Dao, Michael Considine, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 24, 2011
Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinomaRobert A Soslow, Guangming Han, Kay J Park, et al.
Gynecologic Oncology|November 22, 2012
Validated gene targets associated with curatively treated advanced serous ovarian carcinomaJoyce N Barlin, Petar Jelinic, Narciso Olvera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2014
Blocking and randomization to improve molecular biomarker discoveryLi-Xuan Qin, Qin Zhou, Faina Bogomolniy, et al.
The American Journal of Surgical Pathology|December 13, 2012
BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomasKaruna Garg, Douglas A Levine, Narciso Olvera, et al.
Gynecologic Oncology|September 23, 2022
The role of CTNNB1 mutations and matrix metalloproteinases (MMPs) in anti-angiogenesis treatment of endometrial carcinomaAmnon A Berger, Emily A Kawaler, Fanny Dao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2015
Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic typePetar Jelinic, Brooke A Schlappe, Niamh Conlon, et al.
Scientific Reports|June 17, 2017
miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine CarcinosarcomasJill H Tseng, Maria Bisogna, Lien N Hoang, et al.
Gynecologic Oncology|March 1, 2011
A microRNA survival signature (MiSS) for advanced ovarian cancerKarin K Shih, Li-Xuan Qin, Edward J Tanner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinomaDestin Black, Robert A Soslow, Douglas A Levine, et al.
Nature Communications|October 19, 2017
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinomaJennifer Ducie, Fanny Dao, Michael Considine, et al.
Pageof 4